NCT00461552View on ClinicalTrials.gov

Therapeutic Approaches to HAART-Induced Lipodystrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
HIV InfectionsLipodystrophy
Interventions
DRUG

Leptin

weight based, sub-cutaneous injection, twice daily

OTHER

Placebo

weight based, sub-cutaneous injection, twice daily

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

Sponsors
All Listed Sponsors
collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER

NCT00461552 - Therapeutic Approaches to HAART-Induced Lipodystrophy | Biotech Hunter | Biotech Hunter